Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury

Cell Res. 2013 Apr;23(4):577-80. doi: 10.1038/cr.2013.25. Epub 2013 Feb 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / complications
  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / immunology
  • Acute Lung Injury / mortality
  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antiviral Agents / pharmacology*
  • Chemokine CXCL10 / antagonists & inhibitors
  • Chemokine CXCL10 / deficiency
  • Chemokine CXCL10 / genetics
  • Chemokine CXCL10 / immunology*
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / growth & development
  • Influenza A Virus, H1N1 Subtype / immunology
  • Mice
  • Mice, Knockout
  • Orthomyxoviridae Infections / complications
  • Orthomyxoviridae Infections / drug therapy*
  • Orthomyxoviridae Infections / immunology
  • Orthomyxoviridae Infections / mortality
  • Survival Analysis

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents
  • Chemokine CXCL10
  • Cxcl10 protein, mouse